Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.

NCT: NCT03495050 · COMPLETED

NCT IDNCT03495050
StatusCOMPLETED
Start Date2018-06-05
Completion2020-12-17
SponsorClinique Pasteur (OTHER)
First posted
Last updated

Brief Summary

Prospective non interventional, observational registry of 150 patients undergoing TAVI with Evolut platform for bicuspid aortic stenosis.

Frequently Asked Questions

What is BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.?

BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience. is a clinical trial registered under NCT03495050. Current status: COMPLETED.

What is the status of NCT03495050?

The current status of NCT03495050 (BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.) is: COMPLETED.

When did BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience. start?

BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience. started on 2018-06-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑